Oligo Trend

OligoTrend is a privately-held diagnostics company focused on developing and supplying essential oligonucleotide components for PCR-based infectious disease testing. Leveraging expertise in nucleic acid chemistry and assay design since 2011, the company has established a track record in pathogen detection, notably scaling its operations to perform hundreds of thousands of tests, including for COVID-19. Its business model is service and reagent-based, catering to the urgent needs of clinical diagnostics rather than developing therapeutic drugs. The company appears to be revenue-generating through its diagnostic testing services and reagent offerings.

Design, synthesis, and validation platform for oligonucleotide primers and probes used in quantitative real-time PCR (qPCR) diagnostic assays for pathogen detection.

OligoTrend competes in the crowded molecular diagnostics space against multinational giants (e.g., Roche, Thermo Fisher) and numerous specialty firms. Its differentiation lies in its focused expertise in oligonucleotide design and its operational role as a testing service lab, but it faces constant pressure on pricing, technology, and market access.